Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01786629 · ClinicalTrials.gov registry record · Phase 4
BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects
A Phase 4 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 4
- Development phase
- 338
- Enrollment target
NCT01786629 is a Phase 4 study that has completed, run by Braintree Laboratories. The registered enrollment target is 338 participants.
The verdict
NCT01786629, a Phase 4 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 338 participants
- Enrollment target
Study Summary
To compare the safety, tolerance and efficacy of SUPREP Bowel Prep Kit to an FDA approved control as bowel preparations prior to colonoscopy in adult patients.
Interventions
- DRUG SUPREP Bowel Prep Kit
- DRUG FDA approved bowel preparation containing electrolytes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01786629
The ClinicalTrials.gov registry entry for NCT01786629 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SUPREP Bowel Prep Kit is the first listed.
NCT01786629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01786629 about?
NCT01786629 is a clinical study titled "BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects". To compare the safety, tolerance and efficacy of SUPREP Bowel Prep Kit to an FDA approved control as bowel preparations prior to colonoscopy in adult patients.
What is the current status of trial NCT01786629?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 338 participants. The study started on 2012-12.
What interventions are being tested in trial NCT01786629?
The interventions under investigation include: SUPREP Bowel Prep Kit (DRUG), FDA approved bowel preparation containing electrolytes (DRUG).
Who is sponsoring clinical trial NCT01786629?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.